Simply Oncology Podcast Por John McGrane & Michael Rowe arte de portada

Simply Oncology

Simply Oncology

De: John McGrane & Michael Rowe
Escúchala gratis

Welcome to Simply Oncology.
Cancer is daunting for both patients and for clinical teams.
Dr John McGrane and Dr Michael Rowe are oncologists who want to break down the complex parts of cancer care into clear and simple sessions.
We will dive deep into the world of cancer research, patient stories and the latest cancer breakthroughs.
Simply Oncology will have patient focused episodes along with episodes that allow anyone with an interest in oncology to stay up to date.

We hope you join us as we unpick all parts of cancer.

John & Mike

© 2025 Simply Oncology Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Episode 59: Discussing the evidence for Renal SABR and its role in renal carcinoma with Dr Harshani Green (part 2)

    Episode 59: Discussing the evidence for Renal SABR and its role in renal carcinoma with Dr Harshani Green (part 2)
    Jul 18 2025

    Send us a text

    We are back again discussing stereotactic ablative body radiotherapy (SABR) with Dr Harshani Green from the Royal Marsden Hospital.

    Join us if :

    - You want to hear about the evidence from the FASTRACK II trial using renal SABR

    - You are a centre thinking about setting up renal SABR

    - You want to hear about the challenges of comparing renal SABR with surgery

    Will radiotherapy be able to replace cytoreductive nephrectomy in metastatic renal carcinoma?

    We discuss this and more (plus Mike produces a Magic Lamp!)

    Enjoy
    Más Menos
    24 m
  • Episode 58: Exploring Renal SABR (Part 1) with Dr Harshani Green

    Episode 58: Exploring Renal SABR (Part 1) with Dr Harshani Green
    Jul 10 2025

    Send us a text

    Join us for Part 1 of our 2 part Simply Oncology podcast with Dr Harshani Green on Stereotactic Ablative Body Radiotherapy (SABR) in Renal Cell Carcinoma.

    We discuss the role of high precision radiotherapy treating renal cell carcinoma in those patients where an operation may not be possible.

    - We discuss the excellent control rates

    - What size of tumour can we treat?

    - Will we ever be able to compare Surgery versus SABR for primary renal cell carcinoma cancers?
    Más Menos
    24 m
  • Episode 57: Discussing bladder surgery and the GUSTO trial in Bladder Cancer with Professor Jim Catto

    Episode 57: Discussing bladder surgery and the GUSTO trial in Bladder Cancer with Professor Jim Catto
    Jun 20 2025

    Send us a text

    Surgery in Bladder Cancer Bumper episode!
    We talk to Professor Jim Catto about surgery in Bladder Cancer.
    🎙️we discuss the GUSTO trial stratifying bladder cancer therapy by molecular subtype
    🎙️we look at quality of life and #cystectomy🎙️we look at surgical outcomes from NIAGARA
    🎙️we look at peri-operative trials

    A bumper Bladder Cancer issue
    Más Menos
    37 m
Todavía no hay opiniones